Itaconate alleviates β2-microglobulin-induced cognitive impairment by enhancing the hippocampal amino-β-carboxymuconate-semialdehyde-decarboxylase/picolinic acid pathway
- 11 June 2022
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 202, 115137
Abstract
No abstract availableKeywords
Funding Information
- Scientific Research Foundation of Hunan Provincial Education Department (21B0429)
- National Natural Science Foundation of China (81971267)
This publication has 35 references indexed in Scilit:
- The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disordersBritish Journal of Pharmacology, 2013
- Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid productionProceedings of the National Academy of Sciences, 2013
- Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal NeurogenesisNeuropsychopharmacology, 2011
- MHCI negatively regulates synapse density during the establishment of cortical connectionsNature Neuroscience, 2011
- Immune modulation of learning, memory, neural plasticity and neurogenesisBrain, Behavior, and Immunity, 2011
- Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative DisordersAntioxidants & Redox Signaling, 2010
- Epigenetic choreographers of neurogenesis in the adult mammalian brainNature Neuroscience, 2010
- Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's DiseaseCell Stem Cell, 2009
- Cognitive Impairment in the Aging Dialysis and Chronic Kidney Disease Populations: An Occult BurdenAdvances in Chronic Kidney Disease, 2008
- Milestones of neuronal development in the adult hippocampusTrends in Neurosciences, 2004